https://www.thebodypro.com/author/myles-helfand
Myles Helfand Img

Myles Helfand

Executive Editor

Myles is the executive editor and general manager of TheBody/TheBodyPro. A career journalist and editor, Myles joined TheBody in 2001 as a part-time copyeditor. He has since established himself as a leading journalist and content strategist on HIV-related issues, authoring hundreds of articles and editing hundreds more -- and accumulating an ever-growing mountain of HIV conference badges along the way.

Latest by Myles Helfand

doctor patient hands
News

This Week in HIV Research: Health in Unity

Jan. 21, 2021: Dyad-level interventions in serodiscordant relationships; using social media to improve PrEP uptake; HCV prevalence among MSM; the irrelevance of doxycycline prophylaxis against mycoplasma genitalium.

By Barbara Jungwirth and Myles Helfand
rocky road
News

This Week in HIV Research: A Patient’s History Really Matters

Jan. 14, 2021: Interpersonal violence history and adverse HIV outcomes; the incidence and severity of breast cancer; the effect of menopause on integrase-associated weight gain; two-drug therapy for HIV treatment-experienced people.

By Barbara Jungwirth and Myles Helfand
healthcare dark
News

This Week in HIV Research: Delivering Care Through Uncertainty

Jan. 7, 2021: HIV status and COVID-19 disease severity; associations between tobacco smoking, cancer incidence, viral load, and CD4 count; immune recovery on integrase inhibitors; using smart pill bottles to boost adherence.

By Barbara Jungwirth and Myles Helfand
nurse patient hands
Reference

What's New in U.S. HIV Clinical Treatment Guidelines

The latest update to official guidelines issued by the U.S. Department of Health and Human Services on the treatment and care of people living with HIV occurred within the perinatal HIV prevention guidelines on Dec. 20.

By Myles Helfand
teamwork
News

This Week in HIV Research: Teamwork Makes the Dream Work

Dec. 28, 2020: The power of clinic-pharmacy collaborations; overcoming COVID-19-induced barriers to HIV care; urine testing as a PrEP adherence tool; using incarceration history in PrEP Rx assessments.

By Barbara Jungwirth and Myles Helfand
rear view mirror
News

This Week in HIV Research: Taking Stock of Our Epidemic

Dec. 17, 2020: HIV-related mortality in the U.S.; trends in extensive multidrug resistance; 96-week fostemsavir data; statins for microbial cancer prevention.

By Barbara Jungwirth and Myles Helfand
priority
News

This Week in HIV Research: Are Our Priorities in the Right Place?

Dec. 10, 2020: Where the Ending the HIV Epidemic plan falls short; housing instability and HIV care incentives; financial wellbeing vs. health care access; San Diego's complex webs of HIV transmission.

By Barbara Jungwirth and Myles Helfand
Promo Image
News

This Week in HIV Research: Our Immensely Intersectional Epidemic

Dec. 3, 2020: A simple scoring system for PrEP referral; integrating meth use and HIV prevention interventions; genetically linked HIV strains cross county lines; viral suppression rates in first vs. second pregnancies.

By Barbara Jungwirth and Myles Helfand
complicated knot
News

This Week in HIV Research: Untangling Knots of Comorbidities

Nov. 19, 2020: Metformin's effect on weight and gut microbiota; integrase and cardiometabolics in women with HIV; ongoing link between HIV, smoking, and cancer; how early HIV treatment initiation impacts future cervical cancer outcomes.

By Barbara Jungwirth and Myles Helfand
Promo Image
News

This Week in HIV Research: What’s in Your Head

Nov. 12, 2020: The most significant burdens experienced by PLWH; asymptomatic neurocognitive impairment and HAND risk; financial incentives for improving HIV knowledge and testing; linking HIV and COVID-19 testing.

By Barbara Jungwirth and Myles Helfand